No evidence supporting the use of individualised herbal medicine in any indication

Focus on Alternative and Complementary Therapies

Volumn 12, Issue 4, 2007, Pages 244-247

  Guo, Ruoling ^a   Canter, Peter H ^a   Ernst, Edzard ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Ayurvedic medicine; Chinese herbal medicine; Individualised herbal medicine; Medical herbalism; Phytomedicine; Systematic review

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ASCORBIC ACID; CHINESE DRUG; FLUOROURACIL; FOLINIC ACID; HERBACEOUS AGENT; MINERAL; MULTIVITAMIN; OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; AYURVEDA; BLOOD TOXICITY; BREAST CANCER; CHINESE MEDICINE; CLINICAL TRIAL; COLON CANCER; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH PRACTITIONER; HERBAL MEDICINE; HUMAN; IRRITABLE COLON; KNEE OSTEOARTHRITIS; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; PRESCRIPTION; PUBLICATION; TREATMENT DURATION;

EID: 36949004760     PISSN: 14653753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Bensoussan A, Talley NJ, Hing M et al. Treatment of irritable bowel syndrome with Chinese herbal medicine. JAMA 1998; 280: 1585-89.
2. Hamblin L, Laird A, Walker AF. Reduced osteoarthritis symptoms from practitioner-prescribed herbal treatment: a randomised, double-blind feasibility study (pre-publication draft of a study under review, 2007).
3. Mok TSK, Yeo W, Johnson PJ et al. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. Ann Oncol 2007; 18: 768-74.